Scarletred Celebrates 10 Year Anniversary: Revolutionizing Digital Health and Dermatology

Author

Fiona Schmidt

Scarletred, a pioneering force in the digital health sector, is proud to celebrate its 10-year anniversary. Our technology has achieved remarkable growth, transforming the landscape of skin condition research and diagnostics.

A Decade of Innovation and Growth

From its beginnings in Vienna, Scarletred® has grown into a global leader in the field of dermatological diagnostics. The company’s flagship product, Scarletred®Vision, has become a cornerstone for medical and healthcare professionals worldwide, offering a state-of-the-art solution for monitoring, diagnostic support, and researching over 3000 skin conditions. This includes common issues such as atopic dermatitis, psoriasis, and chronic wounds in elderly patients, as well as more complex cases like skin cancers and rare dermatological disorders.

The Mercur Award 2016 with Harald and Kathrin Schnidar - one of Scarletred’s first awards with many more to come.

‍

Scarletred®Vision, a CE Class 1m-certified medical device, allows for non-invasive skin imaging and analysis through an AI-driven platform. Founded by Austrian entrepreneur Harald Schnidar, MBA, PhD, in 2014, it was developed from the idea of innovating and standardizing the imaging process of radiation-induced dermatitis. He brings over 20 years of experience in skin drug research, medical device development, bioinformatics, and artificial intelligence. His journey began at the Universities of Graz and Salzburg before transitioning into the biotechnology industry, leading preclinical and clinical skin drug development.

This innovative approach has not only improved the accuracy of skin condition assessments but has also made it possible for healthcare providers to offer remote monitoring, thereby increasing access to care for patients in underserved regions.

State Prize Digital Solutions 2017 of the Federal Ministry of Science, Research and Economics with the Scarletred-Team.

Empowering Healthcare Professionals

Over the past decade, Scarletred® has empowered thousands of healthcare professionals across more than 30 countries among the pharmaceutical and cosmetic industry and academia. The platform’s user-friendly interface and robust data analytics tools have been instrumental in streamlining the diagnostic process as a AI-powered decision support tool, enabling clinicians to make more informed decisions in a fraction of the time.

The company’s commitment to supporting medical research has also been a key driver of its success. By providing a reliable and scalable tool for clinical trials, Scarletred®Vision has facilitated numerous studies aimed at understanding and treating various skin conditions. This has led to breakthroughs in treatment protocols and a better understanding of skin health at the molecular level.

Scarletred’s first publication 128 shades of red, creating the patented Standardized Erythema Value (SEV*).

New Milestones: AI-Powered Consultation Service and Global Outreach

In addition to its technological advancements, Scarletred® has introduced an AI-powered consultation service at the Seestadt Apotheke in Vienna, offering patients access to expert consultation in real-time. This service has become a model for how AI can be integrated into everyday healthcare, making specialized consultations more accessible to the general public.

Scarletred® has also established itself as a key player in the global medical community over the years through its sponsorship of and participation in prestigious events such as the Dermatology Drug Development Summit in the USA and Europe, the Inflammatory Skin Disease Summit, the annual AAD Meeting, and many more. These engagements highlight the company’s commitment to staying at the forefront of research and innovation.

Part of the Scarletred Team as a sponsor of the Inflammatory Skin Disease Summit in Vienna, Austria.

A Bright Future Ahead

As Scarletred® embarks on its second decade, the company’s impact on dermatology and digital health is undeniable. With the recent addition of texture analysis to the Scarletred®Vision platform, healthcare professionals can now assess skin conditions with even greater precision. The company is also focused on expanding the capabilities of its technology, integrating new AI algorithms, and enhancing its global reach.

Dr. Harald Schnidar, the visionary behind Scarletred®, reflected on the journey so far:

"We are incredibly proud of what we have achieved in the past ten years. Our mission has always been to innovate and to improve patient care. As we look to the future, we remain dedicated to pushing the boundaries of what’s possible in digital health, and we are excited to continue supporting healthcare professionals and clinical research industry with their vital work."

With continued innovation, a dedicated team, and a clear vision for the future, Scarletred® is committed to being at the forefront of skin health technology for years to come.

Contact us via office@scarletred.com.